FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC
$AQST
Biotechnology: Pharmaceutical Preparations
Health Care
New Drug Application (NDA): 218623
Company: AQUESTIVE THERAPEUTICS INC
Company: AQUESTIVE THERAPEUTICS INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| LIBERVANT | DIAZEPAM | 5MG | FILM;BUCCAL | Prescription | None | No | No |
| LIBERVANT | DIAZEPAM | 7.5MG | FILM;BUCCAL | Prescription | None | No | No |
| LIBERVANT | DIAZEPAM | 10MG | FILM;BUCCAL | Prescription | None | No | No |
| LIBERVANT | DIAZEPAM | 12.5MG | FILM;BUCCAL | Prescription | None | No | No |
| LIBERVANT | DIAZEPAM | 15MG | FILM;BUCCAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/26/2024 | ORIG-1 | Approval | STANDARD |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218623s000lbl.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 04/26/2024 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218623s000lbl.pdf |